COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aclaris Therapeutics, Inc. | Common Stock | 00461U105 | 26,972 | 1,539,480 | SH | | SOLE | | 1,539,480 | 0 | 0 |
Adamas Pharmaceuticals, Inc. | Common Stock | 00548A106 | 387 | 16,206 | SH | | SOLE | | 16,206 | 0 | 0 |
Aduro Biotech, Inc. | Common Stock | 00739L101 | 155 | 16,694 | SH | | SOLE | | 16,694 | 0 | 0 |
Affimed N.V. | Common Stock | N01045108 | 205 | 110,834 | SH | | SOLE | | 110,834 | 0 | 0 |
Aimmune Therapeutics, Inc. | Common Stock | 00900T107 | 646 | 20,308 | SH | | SOLE | | 20,308 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | Common Stock | 015351109 | 1,017 | 9,126 | SH | | SOLE | | 9,126 | 0 | 0 |
Allergan plc | Common Stock | G0177J108 | 1,578 | 9,379 | SH | | SOLE | | 9,379 | 0 | 0 |
Amarin Corp PLC | Common Stock | 023111206 | 9,998 | 3,321,588 | SH | | SOLE | | 3,321,588 | 0 | 0 |
Apellis Pharmaceuticals, Inc | Common Stock | 03753U106 | 20,159 | 911,752 | SH | | SOLE | | 911,752 | 0 | 0 |
Ardelyx, Inc. | Common Stock | 039697107 | 501 | 99,166 | SH | | SOLE | | 99,166 | 0 | 0 |
Ascendis Pharma A/S | Common Stock | 04351P101 | 162,160 | 2,479,514 | SH | | SOLE | | 2,479,514 | 0 | 0 |
AstraZeneca PLC | ADRS | 046353108 | 763 | 21,832 | SH | | SOLE | | 21,832 | 0 | 0 |
aTyr Pharma Inc | Common Stock | 002120103 | 4,945 | 1,866,126 | SH | | SOLE | | 1,866,126 | 0 | 0 |
Audentes Therapeutics | Common Stock | 05070R104 | 41,478 | 1,380,303 | SH | | SOLE | | 1,380,303 | 0 | 0 |
Auris Medical Holding AG | Common Shares | H0381L104 | 1,251 | 781,818 | SH | | SOLE | | 781,818 | 0 | 0 |
Bristol-Myers Squibb Company | Common Stock | 110122108 | 951 | 15,033 | SH | | SOLE | | 15,033 | 0 | 0 |
Calithera Biosciences, Inc. | Common Stock | 13089P101 | 126 | 19,928 | SH | | SOLE | | 19,928 | 0 | 0 |
Catalyst Pharmaceuticals, Inc. | Common Stock | 14888U101 | 354 | 148,055 | SH | | SOLE | | 148,055 | 0 | 0 |
Chiasma, Inc. | Common Stock | 16706W102 | 2,445 | 1,630,221 | SH | | SOLE | | 1,630,221 | 0 | 0 |
Cidara Therapeutics, Inc. | Common Stock | 171757107 | 52 | 12,952 | SH | | SOLE | | 12,952 | 0 | 0 |
Clearside Biomedical, Inc. | Common Stock | 185063104 | 380 | 35,379 | SH | | SOLE | | 35,379 | 0 | 0 |
Coherus BioSciences, Inc. | Common Stock | 19249H103 | 31,970 | 2,893,221 | SH | | SOLE | | 2,893,221 | 0 | 0 |
Dermira, Inc. | Common Stock | 24983L104 | 386 | 48,320 | SH | | SOLE | | 48,320 | 0 | 0 |
Edge Therapeutics, Inc. | Common Stock | 279870109 | 3,366 | 2,852,711 | SH | | SOLE | | 2,852,711 | 0 | 0 |
Exelixis Inc | Common Stock | 30161Q104 | 206 | 9,300 | SH | Call | SOLE | | 0 | 0 | 0 |
Foamix Pharmaceuticals Ltd. | Common Stock | M46135105 | 369 | 72,017 | SH | | SOLE | | 72,017 | 0 | 0 |
GW Pharmaceuticals PLC | Common Stock | 36197T103 | 410 | 3,637 | SH | | SOLE | | 3,637 | 0 | 0 |
Heron Therapeutics, Inc. | Common Stock | 427746102 | 832 | 30,133 | SH | | SOLE | | 30,133 | 0 | 0 |
Histogenics Corporation | Common Stock | 43358V109 | 5,712 | 2,077,040 | SH | | SOLE | | 2,077,040 | 0 | 0 |
Ionis Pharmaceuticals, Inc. | Common Stock | 462222100 | 374 | 8,476 | SH | | SOLE | | 8,476 | 0 | 0 |
Iovance Biotherapeutics, Inc. | Common Stock | 462260100 | 523 | 30,958 | SH | | SOLE | | 30,958 | 0 | 0 |
Kadmon Holdings, Inc. | Common Stock | 48283N106 | 539 | 126,865 | SH | | SOLE | | 126,865 | 0 | 0 |
Kadmon Holdings, Inc. | Warrant | 48283N106 | 255 | 59,909 | SH | | SOLE | | 0 | 0 | 0 |
Kala Pharmaceuticals, Inc. | Common Stock | 483119103 | 323 | 20,409 | SH | | SOLE | | 20,409 | 0 | 0 |
MediciNova, Inc. | Common Stock | 58468P206 | 336 | 32,875 | SH | | SOLE | | 32,875 | 0 | 0 |
Merus N.V. | Common Stock | N5749R100 | 36,338 | 1,961,039 | SH | | SOLE | | 1,961,039 | 0 | 0 |
Mirati Therapeutics, Inc. | Common Stock | 60468T105 | 267 | 8,688 | SH | | SOLE | | 8,688 | 0 | 0 |
Natera, Inc. | Common Stock | 632307104 | 28,742 | 3,100,560 | SH | | SOLE | | 3,100,560 | 0 | 0 |
NuCana plc | American Depositary Shares | 67022C106 | 88,293 | 4,666,666 | SH | | SOLE | | 4,666,666 | 0 | 0 |
ObsEva SA | Common Stock | H5861P103 | 64,096 | 4,749,623 | SH | | SOLE | | 4,749,623 | 0 | 0 |
OncoMed Pharmaceuticals, Inc. | Common Stock | 68234X102 | 213 | 67,033 | SH | | SOLE | | 67,033 | 0 | 0 |
OncoSec Medical Incorporated | Common Stock | 68234L207 | 126 | 66,965 | SH | | SOLE | | 66,965 | 0 | 0 |
Otonomy, Inc. | Common Stock | 68906L105 | 414 | 98,624 | SH | | SOLE | | 98,624 | 0 | 0 |
PTC Therapeutics, Inc. | Common Stock | 69366J200 | 696 | 25,729 | SH | | SOLE | | 25,729 | 0 | 0 |
Radius Health Inc. | Common Stock | 750469207 | 605 | 16,847 | SH | | SOLE | | 16,847 | 0 | 0 |
Reata Pharmaceuticals Inc | Common Stock | 75615P103 | 603 | 29,383 | SH | | SOLE | | 29,383 | 0 | 0 |
Regeneron Pharmaceuticals, Inc. | Common Stock | 75886F107 | 449 | 1,304 | SH | | SOLE | | 1,304 | 0 | 0 |
Rigel Pharmaceuticals, Inc | Common Stock | 766559603 | 252 | 71,300 | SH | Put | SOLE | | 71,300 | 0 | 0 |
Rigel Pharmaceuticals, Inc. | Common Stock | 766559603 | 365 | 102,974 | SH | | SOLE | | 102,974 | 0 | 0 |
Sierra Oncology, Inc. | Common Stock | 82640U107 | 203 | 98,126 | SH | | SOLE | | 98,126 | 0 | 0 |
Spark Therapeutics, Inc. | Common Stock | 84652J103 | 32,048 | 481,270 | SH | | SOLE | | 481,270 | 0 | 0 |
Spectrum Pharmaceuticals Inc. | Common Stock | 84763A108 | 241 | 15,000 | SH | Call | SOLE | | 0 | 0 | 0 |
Stemline Therapeutics INC | Common Stock | 85858C107 | 193 | 12,640 | SH | | SOLE | | 12,640 | 0 | 0 |
Syndax Pharmaceuticals, Inc. | Common Stock | 87164F105 | 173 | 12,124 | SH | | SOLE | | 12,124 | 0 | 0 |
Synlogic, Inc. | Common Stock | 87166L100 | 5,393 | 574,972 | SH | | SOLE | | 574,972 | 0 | 0 |